Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Maria Labrador

3PUBLICATIONS

13CO-AUTHORS

Molecular targetsCancer cell biology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|May 13, 2026

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Oct 16, 2024

IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.

Roberto Piva, Nariman Gharari, Maria Labrador

|May 16, 2023

Euchromatic Histone Lysine Methyltransferase 2 Inhibition Enhances Carfilzomib Sensitivity and Overcomes Drug Resistance in Multiple Myeloma Cell Lines.

Elisabetta Mereu, Damiano Abbo, Tina Paradzik

Pageof 1

Frequent Collaborators

3 joint publications

Roberto Piva

2 joint publications

Tina Paradzik

2 joint publications

Domenica Ronchetti

2 joint publications

Veronica Manicardi

1 joint publications

Sylvie Mader

1 joint publications

Mariangela Porro

1 joint publications

Benedetta Donati

1 joint publications

Mattia D'Agostino

1 joint publications

Francesca Gay

1 joint publications

Benedetto Bruno

Frequent Collaborators

3 joint publications

Roberto Piva

2 joint publications

Tina Paradzik

2 joint publications

Domenica Ronchetti

2 joint publications

Veronica Manicardi